H.R.6347: To extend for one year the program for priority review to encourage treatments for rare pediatric diseases.

About This Bill

  • This bill was introduced in the 114th Congress
  • This bill is primarily about health
  • Introduced Nov. 17, 2016
  • Latest Major Action Nov. 17, 2016

Bill Summary

This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2017 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.)

(Source: Library of Congress)

Bill Actions

Date Description
Nov. 17, 2016
Referred to the House Committee on Energy and Commerce.
Nov. 17, 2016

Introduced in the House by Alan Grayson (D-Fla.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page